Literature DB >> 29717469

The Distinction Between Curative and Assistive Technology.

Joseph A Stramondo1.   

Abstract

Disability activists have sometimes claimed their disability has actually increased their well-being. Some even say they would reject a cure to keep these gains. Yet, these same activists often simultaneously propose improvements to the quality and accessibility of assistive technology. However, for any argument favoring assistive over curative technology (or vice versa) to work, there must be a coherent distinction between the two. This line is already vague and will become even less clear with the emergence of novel technologies. This paper asks and tries to answer the question: what is it about the paradigmatic examples of curative and assistive technologies that make them paradigmatic and how can these defining features help us clarify the hard cases? This analysis will begin with an argument that, while the common views of this distinction adequately explain the paradigmatic cases, they fail to accurately pick out the relevant features of those technologies that make them paradigmatic and to provide adequate guidance for parsing the hard cases. Instead, it will be claimed that these categories of curative or assistive technologies are defined by the role the technologies play in establishing a person's relational narrative identity as a member of one of two social groups: disabled people or non-disabled people.

Entities:  

Keywords:  Assistive technology; Bioethics; Brain–computer interface; Disability; Neuroethics; Philosophy of medicine; Relational narrative identity

Mesh:

Year:  2018        PMID: 29717469     DOI: 10.1007/s11948-018-0058-9

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  1 in total

1.  Brain-computer interfaces and disability: extending embodiment, reducing stigma?

Authors:  Sean Aas; David Wasserman
Journal:  J Med Ethics       Date:  2015-09-03       Impact factor: 2.903

  1 in total
  1 in total

1.  Assessing potential cures: are there distinctive elements of value beyond health gain?

Authors:  Saskia Hendriks; Steven D Pearson
Journal:  J Comp Eff Res       Date:  2021-03-05       Impact factor: 1.744

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.